Natural Products as Novel Therapeutic Agents for Triple-Negative Breast Cancer: Current Evidence, Mechanisms, Challenges, and Opportunities
Breast cancer (BC) tops the list of causes for female fatalities globally, with the elusive triple-negative breast cancer (TNBC) constituting 10–20% of all cases. Current clinical strategies for combating TNBC encompass a multifaceted approach, including surgical intervention, radiation therapy, che...
Saved in:
| Main Authors: | Qingzhou Li, Zhen Ye, Guilin Wang, Yuhui Chen, Jinghong Deng, Dong Wang, Yumei Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/6/1201 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01) -
Mechanisms of radioresistance and radiosensitization strategies for Triple Negative Breast Cancer
by: Yuxuan Wang, et al.
Published: (2025-05-01) -
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
by: Lucía Serrano García, et al.
Published: (2024-12-01) -
Triple-negative ectopic breast cancer of the male scrotum: a case report
by: Yuhui Nie, et al.
Published: (2024-12-01) -
LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target
by: Qiqi Xue, et al.
Published: (2025-03-01)